- Home
- / Tianjin Pharmaceutical
Tianjin Pharmaceutical
Stock Price
$2.4
2024-10-29
Market Capitalization
$3.2 B
2024-10-29
Revenue
¥4.8 B
FY, 2025
Tianjin Pharmaceutical Summary
Company Summary
- Overview
- Tianjin Pharmaceutical is a manufacturer and distributor of Chinese medicine, western medicine, and healthcare products. Its products include cardiovascular and cerebrovascular, respiratory, spleen and stomach, cold medicines, etc.
- Type
- Public
- Status
- Active
- Founded
- 1992
- Website
- http://www.zhongxinp.com
- Cybersecurity rating
Table of Contents
Tianjin Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥1.5B
- Gross profit (Q1, 2026)
- ¥1.2B
- Net income (Q1, 2026)
- ¥423.1M
- Cash (Q1, 2026)
- ¥902.1M
- EBIT (Q1, 2026)
- ¥491.1M
- Enterprise value
- $2.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026